The trademark application THE EARLY TAVR TRIAL was filed by Edwards Lifesciences Corporation, a U.S. corporation (the "Applicant"). The application was published for oppositions on June 24, 2021, and it was registered by office on September 30, 2021 without any oppositions.
The application was filed in English (French was selected as the second language).
Change of name and address of the trademark registration was recorded on February 26, 2023.